Acute ischemic strokes imply the loss of brain function created by
the lack of blood supply to the brain. The most common cause of acute
ischemic strokes is the formation of atherosclerosis plaques that
narrow or block blood vessels. Another major cause is the formation
of blood clots in the arteries to the brain.
According to the report, the primary factor responsible for the
current growth rate of the global acute ischemic stroke diagnosis and
treatment market is the increasing prevalence of the disease. This
market’s growth rate is further supported by the developments that
modern medicine and medical devices are allowing in it. Due to the
incorporation of these developments, the success rate of surgeries is
improving the world over, causing a higher growth rate to show over
the given forecast period.
Read Report Overview @
https://www.transparencymarketresearch.com/acute-ischemic-stroke-treatment.html
The report’s users can gain deep insights into the acute ischemic
stroke diagnosis and treatment market based on its segmented
analysis, through the categories of surgery type and diagnostic type.
According to surgery type, this market is segmented into endovascular
mechanical thrombectomy, angioplasty, and carotid endarterectomy.
Based on surgery type, this market was dominated by carotid
endaterectomy in 2013, owing to easier availability, shorter length
of treatment time, and a greater success rate. This segment could,
however, experience a fall in market shares due to the presence of
major side effects.
Based on diagnostic type, this market is segmented into nuclear
imaging, cerebral angioplasty, ultrasound, magnetic resonance
imaging, computed tomography, and others. Although CT has dominated
the global acute ischemic stroke diagnosis and treatment market so
far, it is expected to be steadily replaced by the MRI method, owing
to higher efficiency and lower costs.
Request Sample Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1799
The report also provides a detailed geographical review of the acute
ischemic stroke diagnosis and treatment market by segmenting it into
the major zones of North America, Asia Pacific, Europe, and the Rest
of the World.
Owing to a high patient pool and the presence of highly advanced
technologies, this market was dominated by North America in 2013. The
second-largest region in the acute ischemic stroke diagnosis and
treatment market is Europe, owing to the rapidly increasing geriatric
population across this region.
Meanwhile, Asia Pacific is showing the fastest growth rate among all
major regions. This is attributed to the surging healthcare industry,
the growing population density, and the rising rates of awareness and
healthcare expenditures.
The key players in the global acute ischemic stroke diagnosis and
treatment market are Hitachi, Ltd., GE Healthcare, Johnson &
Johnson, Stryker Corporation, Penumbra, Inc., Philips Healthcare,
Siemens Healthcare, Abbott Laboratories, and Covidien plc.
Buy Full Acute Ischemic Stroke Diagnosis and Treatment Market
Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=1799<ype=S
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
http://www.transparencymarketresearch.com/
No comments:
Post a Comment